ALNY logo

Alnylam Pharmaceuticals (ALNY) Working Capital

Annual Working Capital

$2.11 B
+$94.10 M+4.67%

December 31, 2024

Summary

Performance

1-Year Change

+4.67%

3-Year Change

-0.18%

5-Year Change

+54.7%

15-Year Change

+30.15%

ALNY Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.86%
ALNY annual working capital is higher than 96.86% of companies in Healthcare sector

High & Low

All-time High

$2.11 B
ALNY annual working capital is currently -0.18% below its historical high of $2.11 billion

3-Year Low

$1.92 B
ALNY annual working capital is currently +9.60% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ALNY previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ALNY next annual earnings announcement has not yet been scheduled

OtherALNYbalance sheetmetrics:

Annual Book Value

$67.09 M
ALNY annual book value is $67.09 million

Annual Retained Earnings

-$7.29 B
ALNY annual retained earnings is -$7.29 billion

Annual Total Assets

$4.24 B
ALNY annual total assets is $4.24 billion

Annual Total Liabilities

$4.17 B
ALNY annual total liabilities is $4.17 billion

Quarterly Working Capital

$2.11 B
-$25.75 M-1.21%

December 31, 2024

Summary

Performance

3-Month Change

-1.21%

1-Year Change

+4.67%

3-Year Change

+4.67%

5-Year Change

+4.67%

ALNY Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.76%
ALNY quarterly working capital is higher than 96.76% of companies in Healthcare sector

High & Low

All-time High

$2.17 B
ALNY quarterly working capital is currently -2.83% below its historical high of $2.17 billion

3-Year Low

$1.74 B
ALNY quarterly working capital is currently +21.53% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ALNY previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
ALNY next earnings announcement is scheduled for May 2, 2025

OtherALNYbalance sheetmetrics:

Quarterly Book Value

$67.09 M
ALNY quarterly book value is $67.09 million

Quarterly Retained Earnings

-$7.29 B
ALNY quarterly retained earnings is -$7.29 billion

Quarterly Total Assets

$4.24 B
ALNY quarterly total assets is $4.24 billion

Quarterly Total Liabilities

$4.17 B
ALNY quarterly total liabilities is $4.17 billion

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

Annual Working Capital

$2.11 B
ALNY annual working capital is $2.11 billion

Annual Current Assets

$3.30 B
ALNY annual total current assets is $3.30 billion

Annual Current Liabilities

$1.19 B
ALNY annual total current liabilities is $1.19 billion

ALNY Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.7%+4.7%
3 y3 years-0.2%+4.7%
5 y5 years+54.7%+4.7%

ALNY Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.2%+9.6%-1.2%+21.5%
5 y5-year-0.2%+54.7%-2.8%+69.3%
alltimeall time-0.2%>+9999.0%-2.8%>+9999.0%

Alnylam Pharmaceuticals Working Capital History

DateAnnualQuarterly
Dec 2024
$2.11 B(+4.7%)
$2.11 B(-1.2%)
Sep 2024
-
$2.13 B(+0.8%)
Jun 2024
-
$2.12 B(+3.5%)
Mar 2024
-
$2.05 B(+1.6%)
Dec 2023
$2.01 B(+4.7%)
$2.01 B(-1.0%)
Sep 2023
-
$2.04 B(+17.3%)
Jun 2023
-
$1.74 B(-7.1%)
Mar 2023
-
$1.87 B(-2.9%)
Dec 2022
$1.92 B(-8.9%)
$1.92 B(+0.3%)
Sep 2022
-
$1.92 B(+5.7%)
Jun 2022
-
$1.81 B(-8.6%)
Mar 2022
-
$1.98 B(-6.1%)
Dec 2021
$2.11 B(+4.1%)
$2.11 B(+2.3%)
Sep 2021
-
$2.06 B(-4.9%)
Jun 2021
-
$2.17 B(+47.1%)
Mar 2021
-
$1.48 B(-27.3%)
Dec 2020
$2.03 B(+48.9%)
$2.03 B(+28.9%)
Sep 2020
-
$1.57 B(-11.4%)
Jun 2020
-
$1.78 B(+42.5%)
Mar 2020
-
$1.25 B(-8.6%)
Dec 2019
$1.36 B(+33.5%)
$1.36 B(-11.7%)
Sep 2019
-
$1.54 B(-11.0%)
Jun 2019
-
$1.74 B(+39.6%)
Mar 2019
-
$1.24 B(+21.7%)
Dec 2018
$1.02 B(-37.0%)
$1.02 B(-16.3%)
Sep 2018
-
$1.22 B(-12.1%)
Jun 2018
-
$1.39 B(-11.5%)
Mar 2018
-
$1.57 B(-3.1%)
Dec 2017
$1.62 B(+200.0%)
$1.62 B(+81.6%)
Sep 2017
-
$892.32 M(+4.7%)
Jun 2017
-
$851.98 M(+69.9%)
Mar 2017
-
$501.40 M(-7.2%)
Dec 2016
$540.18 M(-48.2%)
$540.18 M(-18.9%)
Sep 2016
-
$665.80 M(-18.6%)
Jun 2016
-
$817.49 M(-16.9%)
Mar 2016
-
$983.71 M(-5.7%)
Dec 2015
$1.04 B(+60.3%)
$1.04 B(+6.0%)
Sep 2015
-
$984.68 M(+2.3%)
Jun 2015
-
$962.55 M(-4.6%)
Mar 2015
-
$1.01 B(+55.1%)
Dec 2014
$651.03 M
$651.03 M(+11.1%)
Sep 2014
-
$586.17 M(-4.1%)
Jun 2014
-
$611.38 M(+3.6%)
DateAnnualQuarterly
Mar 2014
-
$590.23 M(+194.9%)
Dec 2013
$200.16 M(+159.2%)
$200.16 M(+38.7%)
Sep 2013
-
$144.27 M(-10.6%)
Jun 2013
-
$161.29 M(-15.3%)
Mar 2013
-
$190.36 M(+146.5%)
Dec 2012
$77.21 M(+8.7%)
$77.21 M(-57.4%)
Sep 2012
-
$181.18 M(-1.1%)
Jun 2012
-
$183.28 M(+29.2%)
Mar 2012
-
$141.90 M(+99.8%)
Dec 2011
$71.04 M(-53.3%)
$71.04 M(-17.4%)
Sep 2011
-
$86.03 M(-30.5%)
Jun 2011
-
$123.80 M(-18.2%)
Mar 2011
-
$151.37 M(-0.5%)
Dec 2010
$152.09 M(-16.8%)
$152.09 M(+4.8%)
Sep 2010
-
$145.19 M(-15.3%)
Jun 2010
-
$171.48 M(-1.9%)
Mar 2010
-
$174.74 M(-4.4%)
Dec 2009
$182.80 M(-46.8%)
$182.80 M(+43.9%)
Sep 2009
-
$127.04 M(-27.9%)
Jun 2009
-
$176.09 M(-44.1%)
Mar 2009
-
$315.09 M(-8.3%)
Dec 2008
$343.67 M(+9.3%)
$343.67 M(-1.7%)
Sep 2008
-
$349.75 M(-21.4%)
Jun 2008
-
$444.90 M(+20.1%)
Mar 2008
-
$370.56 M(+17.9%)
Dec 2007
$314.43 M(+57.3%)
$314.43 M(-19.4%)
Sep 2007
-
$390.18 M(+123.1%)
Jun 2007
-
$174.85 M(-6.2%)
Mar 2007
-
$186.42 M(-6.7%)
Dec 2006
$199.86 M(+212.6%)
$199.86 M(+89.8%)
Sep 2006
-
$105.30 M(-2.9%)
Jun 2006
-
$108.46 M(-7.4%)
Mar 2006
-
$117.13 M(+83.2%)
Dec 2005
$63.93 M(+53.7%)
$63.93 M(+242.0%)
Sep 2005
-
$18.70 M(-24.7%)
Jun 2005
-
$24.82 M(-29.7%)
Mar 2005
-
$35.30 M(-15.1%)
Dec 2004
$41.61 M(+104.5%)
$41.61 M(+2.6%)
Sep 2004
-
$40.56 M(-3.0%)
Jun 2004
-
$41.81 M(+190.5%)
Mar 2004
-
$14.39 M(-29.3%)
Dec 2003
$20.34 M(+58.4%)
$20.34 M
Dec 2002
$12.85 M
-

FAQ

  • What is Alnylam Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual working capital year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?

What is Alnylam Pharmaceuticals annual working capital?

The current annual working capital of ALNY is $2.11 B

What is the all time high annual working capital for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual working capital is $2.11 B

What is Alnylam Pharmaceuticals annual working capital year-on-year change?

Over the past year, ALNY annual working capital has changed by +$94.10 M (+4.67%)

What is Alnylam Pharmaceuticals quarterly working capital?

The current quarterly working capital of ALNY is $2.11 B

What is the all time high quarterly working capital for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly working capital is $2.17 B

What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, ALNY quarterly working capital has changed by +$94.10 M (+4.67%)